CBD Life Sciences Statistics
Total Valuation
CBDL has a market cap or net worth of 889,800. The enterprise value is 624,279.
| Market Cap | 889,800 |
| Enterprise Value | 624,279 |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CBDL has 5.93 billion shares outstanding. The number of shares has increased by 2,929.02% in one year.
| Current Share Class | 5.93B |
| Shares Outstanding | 5.93B |
| Shares Change (YoY) | +2,929.02% |
| Shares Change (QoQ) | +540.48% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.05 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.12
| Current Ratio | 15.12 |
| Quick Ratio | 14.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.71% and return on invested capital (ROIC) is -11.32%.
| Return on Equity (ROE) | -8.71% |
| Return on Assets (ROA) | -10.81% |
| Return on Invested Capital (ROIC) | -11.32% |
| Return on Capital Employed (ROCE) | -13.58% |
| Weighted Average Cost of Capital (WACC) | 433.41% |
| Revenue Per Employee | 24,580 |
| Profits Per Employee | -12,232 |
| Employee Count | 5 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 78.03 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 23.16 |
| Average Volume (20 Days) | 9,860,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, CBDL had revenue of 98,321 and -48,929 in losses. Loss per share was -0.00.
| Revenue | 98,321 |
| Gross Profit | 41,488 |
| Operating Income | -101,702 |
| Pretax Income | -48,929 |
| Net Income | -48,929 |
| EBITDA | n/a |
| EBIT | -101,702 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 331,598 in cash and n/a in debt, with a net cash position of 331,598 or 0.00 per share.
| Cash & Cash Equivalents | 331,598 |
| Total Debt | n/a |
| Net Cash | 331,598 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 748,728 |
| Book Value Per Share | 0.00 |
| Working Capital | 543,853 |
Cash Flow
| Operating Cash Flow | -139,148 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 42.20%, with operating and profit margins of -103.44% and -49.76%.
| Gross Margin | 42.20% |
| Operating Margin | -103.44% |
| Pretax Margin | -49.76% |
| Profit Margin | -49.76% |
| EBITDA Margin | n/a |
| EBIT Margin | -103.44% |
| FCF Margin | n/a |
Dividends & Yields
CBDL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,929.02% |
| Shareholder Yield | -2,929.02% |
| Earnings Yield | -5.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 22, 2024. It was a reverse split with a ratio of 0.0033333.
| Last Split Date | Apr 22, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0033333 |
Scores
CBDL has an Altman Z-Score of -6.92. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.92 |
| Piotroski F-Score | n/a |